Pioglitazone Metformin Complex Improves Polycystic Ovary Syndrome Comorbid Psychological Distress via Inhibiting NLRP3 Inflammasome Activation: A Prospective Clinical Study
Objective. This study aimed at investigating the therapeutic effect and mechanism of pioglitazone metformin complex preparation (PM) in polycystic ovary syndrome (PCOS) comorbid psychological distress. Methods. Seventy-five patients with PCOS comorbid psychological distress were randomly allocated i...
Saved in:
Main Authors: | Qing-jun Guo, Jing Shan, Yi-feng Xu, Yan-yan Hu, Cui-lan Huo, Jing-yun Song, Chao-qun Wang, Hui Zhou, Chao-qin Yu, Qin Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/3050487 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formononetin ameliorates polycystic ovary syndrome through suppressing NLRP3 inflammasome
by: Zhuo Liu, et al.
Published: (2025-01-01) -
Metformin Ameliorates Ulcerative Colitis Through Inhibiting NLRP3 Inflammasome Activation
by: Cao R, et al.
Published: (2025-02-01) -
Update on the therapeutic role of metformin in the management of polycystic ovary syndrome: Effects on pathophysiologic process and fertility outcomes
by: Kerstin MG Brand, et al.
Published: (2025-01-01) -
Expression of SET Protein in the Ovaries of Patients with Polycystic Ovary Syndrome
by: Xu Boqun, et al.
Published: (2013-01-01) -
NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01)